Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
67.1 USD | +0.22% | -1.18% | -17.36% |
01:55pm | Argus Cuts Price Target on Gilead Sciences to $75 From $85 | MT |
Apr. 22 | Cantor Fitzgerald Adjusts Gilead Sciences' Price Target to $75 From $78, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.36% | 83.48B | |
+25.46% | 659B | |
+26.72% | 557B | |
-4.86% | 359B | |
+16.44% | 322B | |
+8.34% | 297B | |
+6.15% | 215B | |
+5.66% | 210B | |
-6.18% | 200B | |
-8.79% | 149B |
- Stock Market
- Equities
- GILD Stock
- News Gilead Sciences, Inc.
- Insider Trends: Insider at Gilead Sciences Reports Option Conversion in Mist of 90-Day Buying Trend